Charles River Laboratories, Michael J. Fox Foundation Extend Research Partnership

Charles River Laboratories, Michael J. Fox Foundation Extend Research Partnership
Charles River Laboratories International and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) extended their collaboration to accelerate the discovery of Parkinson’s disease therapies. The extension covers grants from MJFF to characterize two animal models of Parkinson’s — one where mice do not express alpha-synuclein (knockout), and another where mice express the Parkinson’s-associated alpha-synuclein mutant A53T (knockin). Alpha-synuclein is the major ... read more
Source: Parkinson’s News TodayPublished on 2018-05-15By Jose Marques Lopes, PhD